LindaCarolLauxMD

Pediatrics • Chicago, IL

Child Neurology

Assistant Professor in Pediatrics, Northwestern University Medical School

Join to view full profile

Dr. Laux is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Laux's full profile

Already have an account?

Office
225 E Chicago Ave
#29
Chicago, IL 60611
Phone+1 312-227-3540

Fax+1 312-227-6940

Education & Training

Phoenix Children's HospitalFellowship, Child Neurology, 1994 - 1997
University of Arizona College of Medicine-TucsonResidency, Pediatrics, 1990 - 1993
Saint Louis University School of MedicineClass of 1990

Certifications & Licensure

IL State Medical License 2000 - 2026
AZ State Medical License 1994 - 2010
American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
American Board of Psychiatry and Neurology Clinical Neurophysiology
American Board of Psychiatry and Neurology Epilepsy

Clinical Trials

Verapamil as Therapy for Children and Young Adults With Dravet Syndrome Start of enrollment: 2012 Apr 01
Completed
Phase 2

Publications & Presentations

PubMed

It's About Time! Timing in Epilepsy Evaluation and Treatment.
Heather Ravvin McKee, Jorge Vidaurre, Dave Clarke, Janelle Wagner, Jeffrey W Britton
Epilepsy Currents. 2024-04-01
14 citations
COVID-19 vaccine in patients with Dravet syndrome: Observations and real-world experiences.
Veronica Hood, Anne T Berg, Kelly G Knupp, Sookyong Koh, Linda Laux
Epilepsia. 2022-07-01
12 citations
Dravet syndrome: A quick transition guide for the adult neurologist.
Danielle M. Andrade, Anne T. Berg, Veronica Hood, Kelly G. Knupp, Sookyong Koh
Epilepsy Research. 2021-08-18

Press Mentions

The Design and Impact of a Hospital-Based Neurodiagnostic Training Program in Electroencephalography and Polysomnography TechnologyAugust 8th, 2024
Antisense Oligonucleotide Shows Potential in Dravet SyndromeDecember 9th, 2022
Stoke Therapeutics : Presents Data from a Combined Interim Analysis of the Phase 1/2a - Form 8-KDecember 2nd, 2022
Join now to see all